The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Models of T cell anergy: is there a common molecular mechanism?
Open accessAbstract
A nergy is a cellular state in which a lymphocyte is ahve but fails to display certain functional responses when optimally stimulated through both its antigen-specific receptor and any other receptors that are normally required for full activation. The term was initially used by Nossal and Pike (1) to describe an unresponsive state induced by the injection o f soluble protein antigens in vivo, in which the antigen-specific B cells were still found to be present in the animal, but these cells could not be reactivated by antigen or mitogen to make Ig. The first observation of proliferative unresponsiveness induced in purified T cells using peptide antigens was made on human CD4 + clones (2). The results were initially interpreted as a direct inactivation of the T cells through recognition o f free antigen; however, subsequent blocking studies with anti-Ia antibodies revealed the involvement of M H C class II molecules (expressed on the T cells; 3). Downregulat ion o f T cell antigen receptor expression was noted after the stimulation and postulated to be the molecular mechanism for the blocking of reactivation (4). Studies with mouse CD4 § T cell clones uncovered other ways of inducing an unresponsive state, which at first appeared to be similar to the nonprohferating state seen with human T cell clones (5, 6). Presentation o f peptide antigens either on chemically fixed APCs (5) or in planar lipid membranes containing only M H C class II molecules (6) was successful, as was stimulation of highly purified T cells with either concanavalin A (7) or ant i -CD3 antibodies coated on a plastic surface (8). These results suggested that occupancy of the T cell antigen receptor alone, in the absence o f other signals, was responsible for inducing the unresponsive state. P roof for this came from so called "allogeneic add-back" experiments in which live APCs bearing allogeneic M H C class II molecules were used to reconstitute the ability to stimulate a prohferative response and prevent the induction of unresponsiveness, even though the allogeneic cells themselves could not present the antigen to the T cell clone (9). The allogeneic APCs were postulated to be delivering a costimulatory signal(s) needed for both effects. W h e n similar allogeneic add-back experiments were carried out with purified human T cell clones inactivated by exposure to high concentrations of soluble peptides, addition o f either allogeneic or syngeneic APC failed to prevent the induction of the unresponsiveness (10). This puzzling observation was further compounded when other laboratories were able to set up mixed leukocyte responses (ML1Ks) using transfected human cell lines as APCs (11) and essentially reproduce as well as extend the earlier findings made in the murine systems (12). Finally, the recent discovery o f partial peptide agonist ligands has led to a new mouse model for anergy in which these peptides were used to induce an unresponsive state, even in the presence o f costimulation (13). The goal o f this commentary is to sort through these various models o f anergy to try and find some c o m m o n underlying molecular mechanism(s) and then to apply these thoughts to the new work of Groux et al. (in this issue). This study adds yet another twist to the induction process, the cytokine IL-10, which with TC1K occupancy produces an anergic state in freshly isolated human CD4 + T ceils that appears to be more profound than any of the previous in vitro models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820
Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H., & Allison, J. P. (1992) · Nature · doi:10.1038/356607a0 · Cited by 1,559
The immune system evolved to discriminate infectious nonself from noninfectious self
Janeway, C. A. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90198-g · Cited by 1,342
Jenkins, M. K., & Schwartz, R. H. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.2.302 · Cited by 1,170
Self-citationLinsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.721 · Cited by 1,127
Induction of apoptosis in mature T cells by tumour necrosis factor
Zheng, L., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H., & Lenardo, M. J. (1995) · Nature · doi:10.1038/377348a0 · Cited by 1,116
lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis
Lenardo, M. J. (1991) · Nature · doi:10.1038/353858a0 · Cited by 1,012
Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo
Kearney, E. R., Pape, K. A., Loh, D. Y., & Jenkins, M. K. (1994) · Immunity · doi:10.1016/1074-7613(94)90084-1 · Cited by 946
JNK is involved in signal integration during costimulation of T lymphocytes
Su, B., Jacinto, E., Hibi, M., Kallunki, T., Karin, M., & Ben-Neriah, Y. (1994) · Cell · doi:10.1016/0092-8674(94)90056-6 · Cited by 906
Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation
Freeman, G. J., Gribben, J. G., Boussiotis, V. A., Ng, J. W., Restivo, V. A., Lombard, L. A., Gray, G. S., & Nadler, L. M. (1993) · Science · doi:10.1126/science.7694363 · Cited by 902
Cited by
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
Pathogenesis of Group A Streptococcal Infections
Cunningham, M. W. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.3.470 · Cited by 2,261
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,623
Schwartz, R. H. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141110 · Cited by 1,487
Self-citationDong, Y., & Benveniste, E. N. (2001) · Glia · doi:10.1002/glia.1107 · Cited by 1,293
Regulatory T cells in the control of immune pathology
Maloy, K. J., & Powrie, F. (2001) · Nature Immunology · doi:10.1038/ni0901-816 · Cited by 1,175
IL-35-mediated induction of a potent regulatory T cell population
Collison, L. W., Chaturvedi, V., Henderson, A. L., Giacomin, P. R., Guy, C., Bankoti, J., Finkelstein, D., Forbes, K., Workman, C. J., Brown, S. A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1952 · Cited by 869
Munn, D. H., Sharma, M. D., Hou, D., Baban, B., Lee, J. R., Antonia, S. J., Messina, J. L., Chandler, P., Koni, P. A., & Mellor, A. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21583 · Cited by 852
Mechanisms of allergen-specific immunotherapy
Akdis, C. A., & Akdis, M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.030 · Cited by 803
Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4
Chang, C. C., Ciubotariu, R., Manavalan, J. S., Yuan, J., Colovai, A. I., Piazza, F., Lederman, S., Colonna, M., Cortesini, R., Dalla-Favera, R., et al. (2002) · Nature Immunology · doi:10.1038/ni760 · Cited by 800
Transcriptional Mechanisms Underlying Lymphocyte Tolerance
Macián, F., Garcı́a-Cózar, F., Im, S.-H., Horton, H. F., Byrne, M. C., & Rao, A. (2002) · Cell · doi:10.1016/s0092-8674(02)00767-5 · Cited by 687
Cbl-b regulates the CD28 dependence of T-cell activation
Chiang, Y. J., Kole, H. K., Brown, K., Naramura, M., Fukuhara, S., Hu, R.-J., Jang, I. K., Gutkind, J. S., Shevach, E., & Gu, H. (2000) · Nature · doi:10.1038/35003235 · Cited by 621
The immunologic basis for the treatment of psoriasis with new biologic agents
Krueger, J. G. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.120568 · Cited by 600
Peled, A., Grabovsky, V., Habler, L., Sandbank, J., Arenzana-Seisdedos, F., Petit, I., Ben-Hur, H., Lapidot, T., & Alon, R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7615 · Cited by 549
Marafioti, T., Hummel, M., Foss, H.-D., Laumen, H., Korbjuhn, P., Anagnostopoulos, I., Lammert, H., Demel, G., Theil, J., Wirth, T., et al. (2000) · Blood · doi:10.1182/blood.v95.4.1443.004k55_1443_1450 · Cited by 499
Steinbrink, K., Graulich, E., Kubsch, S., Knop, J., & Enk, A. H. (2002) · Blood · doi:10.1182/blood.v99.7.2468 · Cited by 448
Drug delivery to mitochondria: the key to mitochondrial medicine
Murphy, M. P., & Smith, R. A. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00069-1 · Cited by 426
Co-stimulation in T cell responses
Chambers, C. A., & Allison, J. P. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80087-8 · Cited by 415
Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux
Shimizu, S., Eguchi, Y., Kamiike, W., Funahashi, Y., Mignon, A., Lacronique, V., Matsuda, H., & Tsujimoto, Y. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1455 · Cited by 410
Pombo, D. J., Lawrence, G., Hirunpetcharat, C., Rzepczyk, C., Bryden, M., Cloonan, N., Anderson, K., Mahakunkijcharoen, Y., Martin, L. B., Wilson, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09784-2 · Cited by 403
IL-10–producing T cells suppress immune responses in anergic tuberculosis patients
Boussiotis, V. A., Tsai, E. Y., Yunis, E. J., Thim, S., Delgado, J. C., Dascher, C. C., Berezovskaya, A., Rousset, D., Reynes, J.-M., & Goldfeld, A. E. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9918 · Cited by 398
Integrating canonical and metabolic signalling programmes in the regulation of T cell responses
Pollizzi, K. N., & Powell, J. D. (2014) · Nature Reviews Immunology · doi:10.1038/nri3701 · Cited by 379
Nemunaitis, J., Dillman, R. O., Schwarzenberger, P. O., Senzer, N., Cunningham, C., Cutler, J., Tong, A., Kumar, P., Pappen, B., Hamilton, C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.5335 · Cited by 367
Immune defects observed in patients with primary malignant brain tumors
Dix, A. R., Brooks, W. H., Roszman, T. L., & Morford, L. A. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00203-9 · Cited by 323
CD28-independent, TRAF2-dependent Costimulation of Resting T Cells by 4-1BB Ligand
Saoulli, K., Lee, S. Y., Cannons, J. L., Yeh, W. C., Santana, A., Goldstein, M. D., Bangia, N., DeBenedette, M. A., Mak, T. W., Choi, Y., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.11.1849 · Cited by 322
Late Complications of Immune Deviation Therapy in a Nonhuman Primate
Genain, C. P., Abel, K., Belmar, N., Villinger, F., Rosenberg, D. P., Linington, C., Raine, C. S., & Hauser, S. L. (1996) · Science · doi:10.1126/science.274.5295.2054 · Cited by 320
Expanding Dendritic Cells In Vivo Enhances the Induction of Oral Tolerance
Viney, J. L., Mowat, A. M., O’Malley, J. M., Williamson, E., & Fanger, N. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.5815 · Cited by 319
Interleukin 2: from immunostimulation to immunoregulation and back again
Bachmann, M. F., & Oxenius, A. (2007) · EMBO reports · doi:10.1038/sj.embor.7401099 · Cited by 303
Human and porcine early kidney precursors as a new source for transplantation
Dekel, B., Burakova, T., Arditti, F. D., Reich-Zeliger, S., Milstein, O., Aviel-Ronen, S., Rechavi, G., Friedman, N., Kaminski, N., Passwell, J. H., et al. (2003) · Nature Medicine · doi:10.1038/nm812 · Cited by 291
Powell, J. D., Lerner, C. G., & Schwartz, R. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.5.2775 · Cited by 289
Self-citationChronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling
Cope, A. P., Liblau, R. S., Yang, X.-D., Congia, M., Laudanna, C., Schreiber, R. D., Probert, L., Kollias, G., & McDevitt, H. O. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1573 · Cited by 287
“Although some of these characteristics are shared by cells that are clonally anergic (34), these findings, together with the observation that chronic TNF can suppress a broad range of T cell responses, suggested partial rather than complete uncoupling of early signaling events within T cells.”
Immunology at the Maternal-Fetal Interface: Lessons for T Cell Tolerance and Suppression
Mellor, A. L., & Munn, D. H. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.367 · Cited by 286
Dependence of Germinal Center B Cells on Expression of CD21/CD35 for Survival
Fischer, M. B., Goerg, S., Shen, L., Prodeus, A. P., Goodnow, C. C., Kelsoe, G., & Carroll, M. C. (1998) · Science · doi:10.1126/science.280.5363.582 · Cited by 282
Ottiger, M., & Bax, A. (1998) · Journal of Biomolecular NMR · doi:10.1023/a:1008366116644 · Cited by 273
The pathogenesis of immune thrombocytopaenic purpura
Cooper, N., & Bussel, J. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06024.x · Cited by 272
Chang, D. T., Jones, J. A., Meyerson, H., Colton, E., Kwon, I. K., Matsuda, T., & Anderson, J. M. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31630 · Cited by 114
“IL-10 inhibits the activation of macrophages and downregulates macrophage costimulatory activity.(35,36) Furthermore, IL-10 can directly inhibit T-cell activation and induce T-cell anergy.”
BUGEON, L., & DALLMAN, M. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.supplement_3.15tac5 · Cited by 94
Metadata
- Authors
- Schwartz, R. H.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1996-07-01
- Volume
- 184
- Issue
- 1
- Pages
- 1-8
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2099748840
- Cited by
- 559
- References
- 65
- FWCI
- 23.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.